Adaptive Biotechnologies Corporation
ADPT
$15.77
-$0.35-2.17%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.48% | 129.82% | 44.58% | 37.16% | 51.59% |
| Total Depreciation and Amortization | -5.69% | -4.05% | -10.01% | -9.26% | -17.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.28% | -5.71% | -33.68% | -10.29% | -66.47% |
| Change in Net Operating Assets | -180.28% | -159.98% | -287.72% | -56.64% | 186.93% |
| Cash from Operations | 116.45% | 73.67% | 28.16% | 25.73% | 53.62% |
| Capital Expenditure | -695.00% | -18.90% | 62.12% | 16.68% | 93.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -134.31% | 214.19% | -47.40% | -41.69% | 392.76% |
| Cash from Investing | -137.31% | 226.90% | -43.07% | -42.54% | 589.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16,953.54% | 4,110.00% | 5,266.67% | 12,288.64% | 45.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16,953.54% | 4,110.00% | 5,266.67% | 12,288.64% | 45.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.49% | 154.47% | 34.42% | -59.03% | 141.27% |